A Wall Street Journal analysis of Medicare data found one in six seniors enrolled in Medicare’s drug benefit were prescribed eight or more medications at the same time.

Demetra Antimisiaris, director of the Jean Frazier Polypharmacy and Medication Management Program (FPMMP) at the University of Louisville Schools of Medicine and Public Health and Information Sciences, shares a disturbing but all too common story that demonstrates the need for education about medication management. She explains how one of her patients living in a long-term care facility was given a medication to treat osteoporosis, but the medicine was administered incorrectly by crushing it first, which led to burning of the patient's esophagus. The patient stopped eating and almost died. "Fortunately, we were able to save her and send her home, where she healed and gained her weight back," Antimisiaris said. "This is an example of the critical importance of medication literacy from the patient to the entire health care team." Polypharmacy, the use of multiple medications together, often associated with medication use risk, is usually associated with older adults, but is increasingly

2025 was a year of recalibration for healthcare. After a period of rapid expansion and capital-driven growth, the market has shifted toward discipline. Employers, payers, and providers have refocused on cost reduction, access, and measurable impact. We have seen digital health adoption continue to grow for solutions that can demonstrate measurable value or cost savings, AI move from promise to practice, and consolidation accelerate as organizations pursue scale and efficiency. As we enter 2026, the question is now which models can endure and empower consumers with proven approaches. Digital-first access will become the default entry point to care. Evidence, transparency, and accountability will be table stakes. And consumers, facing rising costs, will increasingly shape how we access, navigate, and experience care.7wire’s 2026 predictions reflect this transition and outline the forces we believe will define the next phase of connected, consumer-driven healthcare.

The Journals of Gerontology: Series B

Round co-led by Route 66 Ventures and Abundant Venture Partners accelerates expansion of Auxira's integrated virtual care model to expand cardiology capacity

On this episode of The Digital Patient, Dr. Joshua Liu, Co-founder & CEO of SeamlessMD, and colleague, Alan Sardana, chat with Michelle Stansbury, Associate Chief Innovation Officer and Vice President of IT Applications at Houston Methodist, about "Why Siloed Innovation Labs Don’t Work, Making Innovation Financially Accountable, Why Health Systems Must Disrupt Themselves or Risk Being Disrupted, and more..."